Mitotan 500 mg is a key medication for treating adrenocortical carcinoma, now available in India. This drug targets adrenal tumors, decreases hormone levels and inhibits cancer growth. Impomed Healthcare ensures the broad availability of Mitotan 500 mg in India critical treatment across oncology centers, improving patient outcomes and offering new hope. For comprehensive details on Mitotan 500 mg and its impact on cancer treatment, please download and review the attached PDF. For more information click on this link-:https://www.impomedhealthcare.com/